| http://www.w3.org/ns/prov#value | - The procedure of Example 4 is repeated in this example and all conditions are as described except the system is sized, shaped and adapted as an ocular therapeutic system and the drug in the compartment is replaced with an ophthalmic drug that is a member selected from the group consisting of idoxuridine, phenylephrine, pilocarpine hydrochloride, eserine, carbachol, phospholine iodine, demecarium b
|
